Suppr超能文献

颅内脑膜瘤的硬脑膜尾征:抬头还是垂尾?文献系统综述

The dural tail in intracranial meningioma: Heads up or tail down? A systematic review of the literature.

作者信息

Cordia Q C F, Dijkstra B M, Groen R J M

机构信息

Department of Neurosurgery, University Medical Centre Groningen, Hanzeplein 1, P.O. Box 30.001, Groningen, 9700RB, The Netherlands.

Department of Neurosurgery, Maastricht UMC+, Maastricht, The Netherlands.

出版信息

Neurosurg Rev. 2025 Jun 21;48(1):520. doi: 10.1007/s10143-025-03658-z.

Abstract

Meningiomas are the most common primary intracranial tumours. Recurrence occurs in up to 20%, with even higher percentages in atypical or malignant meningiomas. The non-removal of the dural tail may be a risk factor for recurrence. In this review, we aimed to determine the prevalence of tumour tissue in the radiological dural tail sign. Our secondary outcome was to determine the clinical relevance of the dural tail, if possible. PubMed, Embase, ISI Web of Science and the Cochrane Library were systematically searched for studies. Articles evaluating dural tails with both radiological and histopathological findings were included. Two reviewers independently screened studies. Data was extracted manually. 18 articles met the inclusion criteria out of 843 identified reports. In total, 406 patients with a radiological and histopathological evaluated dural tail were found. 286 patients (70.9%) had tumour infiltrate; 110 non-neoplastic dural tails showed vascular changes, loose connective tissue proliferation or inflammation. 65 patients with seemingly normal dura mater were reported, of which 26 (40.0%) showed tumour infiltration. It appears that tumour tissue in the radiological dural tail is common. Concerningly, approximately 40% of non-enhancing dura also revealed tumour tissue in the pathological examination. This highlights the need for further systematic research into the dural tail and its clinical impact on recurrence. Clinical trial number Not applicable.

摘要

脑膜瘤是最常见的原发性颅内肿瘤。高达20%的患者会复发,非典型或恶性脑膜瘤的复发率更高。未切除硬脑膜尾征可能是复发的危险因素。在本综述中,我们旨在确定放射学硬脑膜尾征中肿瘤组织的发生率。如果可能的话,我们的次要结果是确定硬脑膜尾征的临床相关性。我们系统检索了PubMed、Embase、ISI科学网和考科蓝图书馆中的研究。纳入评估硬脑膜尾征的放射学和组织病理学结果的文章。两名评审员独立筛选研究。数据手动提取。在843篇已识别的报告中,18篇文章符合纳入标准。总共发现406例患者的硬脑膜尾征经过了放射学和组织病理学评估。286例患者(70.9%)有肿瘤浸润;110例非肿瘤性硬脑膜尾征表现为血管改变、疏松结缔组织增生或炎症。报告了65例硬脑膜看似正常的患者,其中26例(40.0%)有肿瘤浸润。放射学硬脑膜尾征中的肿瘤组织似乎很常见。令人担忧的是,在病理检查中,约40%的无强化硬脑膜也显示有肿瘤组织。这凸显了对硬脑膜尾征及其对复发的临床影响进行进一步系统研究的必要性。临床试验编号:不适用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/648d/12181092/6c2a4ec8f065/10143_2025_3658_Fig1_HTML.jpg

相似文献

1
The dural tail in intracranial meningioma: Heads up or tail down? A systematic review of the literature.
Neurosurg Rev. 2025 Jun 21;48(1):520. doi: 10.1007/s10143-025-03658-z.
2
123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
Cochrane Database Syst Rev. 2015 Sep 29;2015(9):CD009263. doi: 10.1002/14651858.CD009263.pub2.
4
Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation.
Cochrane Database Syst Rev. 2018 Jan 22;1(1):CD011551. doi: 10.1002/14651858.CD011551.pub2.
6
Clear cell meningioma of the lower lumbar spine without dural attachment: A case report.
Medicine (Baltimore). 2025 Jul 11;104(28):e43193. doi: 10.1097/MD.0000000000043193.
7
Intravesical gemcitabine for non-muscle invasive bladder cancer.
Cochrane Database Syst Rev. 2012 Jan 18;1:CD009294. doi: 10.1002/14651858.CD009294.pub2.
9
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

本文引用的文献

1
Bevacizumab-IRDye800CW for tumor detection in fluorescence-guided meningioma surgery (LUMINA trial): a single-center phase I study.
J Neurosurg. 2024 Jul 5;141(6):1655-1666. doi: 10.3171/2024.4.JNS232766. Print 2024 Dec 1.
2
Single versus multiple reoperations for recurrent intracranial meningiomas.
J Neurooncol. 2024 Jul;168(3):527-535. doi: 10.1007/s11060-024-04673-8. Epub 2024 Apr 24.
4
Location pattern of recurrence of fully resected grade 1 meningiomas.
Acta Neurochir (Wien). 2023 Oct;165(10):2865-2871. doi: 10.1007/s00701-023-05758-5. Epub 2023 Aug 24.
5
Epidemiology of adult meningioma: Report from the Dutch Brain Tumour Registry (2000-2019).
Eur J Neurol. 2023 Oct;30(10):3244-3255. doi: 10.1111/ene.15979. Epub 2023 Jul 21.
6
Radiation of meningioma dural tail may not improve tumor control rates.
Front Surg. 2022 Jul 4;9:908745. doi: 10.3389/fsurg.2022.908745. eCollection 2022.
9
Multiplatform Radiosurgery for Intracranial Meningiomas and Dose to the Dural Tail.
Cureus. 2021 Jan 13;13(1):e12683. doi: 10.7759/cureus.12683.
10
The epidemiology of patients undergoing meningioma resection in Auckland, New Zealand, 2002 to 2011.
J Clin Neurosci. 2020 Oct;80:324-330. doi: 10.1016/j.jocn.2020.06.011. Epub 2020 Jul 6.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验